Literature DB >> 22328062

Functional connectivity measured with magnetoencephalography identifies persons with HIV disease.

James T Becker1, Ricardo Bajo, Melissa Fabrizio, Gustavo Sudre, Pablo Cuesta, Howard J Aizenstein, Oscar L Lopez, David Wolk, Lauri Parkkonen, Fernando Maestu, Anto Bagic.   

Abstract

There is need for a valid and reliable biomarker for HIV Associated Neurocognitive Disorder (HAND). The purpose of the present study was to provide preliminary evidence of the potential utility of neuronal functional connectivity measures obtained using magnetoencephalography (MEG) to identify HIV-associated changes in brain function. Resting state, eyes closed, MEG data from 10 HIV-infected individuals and 8 seronegative controls were analyzed using mutual information (MI) between all pairs of MEG sensors to determine whether there were functional brain networks that distinguished between subject groups based on cognition (global and learning) or on serostatus. Three networks were identified across all subjects, but after permutation testing (at α < .005) only the one related to HIV serostatus was significant. The network included MEG sensors (planar gradiometers) above the right anterior region connecting to sensors above the left posterior region. A mean MI value was calculated across all connections from the anterior to the posterior groupings; that score distinguished between the serostatus groups with only one error (sensitivity = 1.00, specificity = .88 (X ( 2 ) = 15.4, df = 1, p < .01, Relative Risk = .11). There were no significant associations between the MI value and the neuropsychological Global Impairment Rating, substance abuse, mood disorder, age, education, CD4+ cell counts or HIV viral load. We conclude that using a measure of functional connectivity, it may be possible to distinguish between HIV-infected and uninfected individuals, suggesting that MEG may have the potential to serve as a sensitive, non-invasive biomarker for HAND.

Entities:  

Mesh:

Year:  2012        PMID: 22328062      PMCID: PMC3351549          DOI: 10.1007/s11682-012-9149-4

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  33 in total

Review 1.  The brainweb: phase synchronization and large-scale integration.

Authors:  F Varela; J P Lachaux; E Rodriguez; J Martinerie
Journal:  Nat Rev Neurosci       Date:  2001-04       Impact factor: 34.870

2.  Nonparametric permutation tests for functional neuroimaging: a primer with examples.

Authors:  Thomas E Nichols; Andrew P Holmes
Journal:  Hum Brain Mapp       Date:  2002-01       Impact factor: 5.038

Review 3.  Dynamic predictions: oscillations and synchrony in top-down processing.

Authors:  A K Engel; P Fries; W Singer
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

4.  Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients.

Authors:  T Ernst; L Chang; J Jovicich; N Ames; S Arnold
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

5.  Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.

Authors:  Linda Chang; Thomas Ernst; Mallory D Witt; Nina Ames; Megan Gaiefsky; Eric Miller
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

6.  HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998.

Authors:  N Sacktor; R H Lyles; R Skolasky; C Kleeberger; O A Selnes; E N Miller; J T Becker; B Cohen; J C McArthur
Journal:  Neurology       Date:  2001-01-23       Impact factor: 9.910

7.  HIV-associated cognitive impairment before and after the advent of combination therapy.

Authors:  Ned Sacktor; Michael P McDermott; Karen Marder; Giovanni Schifitto; Ola A Selnes; Justin C McArthur; Yaakov Stern; Steve Albert; Donna Palumbo; Karl Kieburtz; Joy A De Marcaida; Bruce Cohen; Leon Epstein
Journal:  J Neurovirol       Date:  2002-04       Impact factor: 2.643

8.  Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART.

Authors:  Linda Chang; Thomas Ernst; Mallory D Witt; Nina Ames; Irwin Walot; Jorge Jovicich; Menaka DeSilva; Neha Trivedi; Oliver Speck; Eric N Miller
Journal:  Antivir Ther       Date:  2003-02

9.  Magnetocephalography: a noninvasive alternative to the Wada procedure.

Authors:  Andrew C Papanicolaou; Panagiotis G Simos; Eduardo M Castillo; Joshua I Breier; Shirin Sarkari; Ekaterina Pataraia; Rebecca L Billingsley; Scott Buchanan; James Wheless; Vijayalakshmi Maggio; William W Maggio
Journal:  J Neurosurg       Date:  2004-05       Impact factor: 5.115

10.  Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.

Authors:  Linda Chang; Thomas Ernst; Coryse St Hillaire; Katherine Conant
Journal:  Antivir Ther       Date:  2004-06
View more
  20 in total

Review 1.  Neuroimaging with magnetoencephalography: A dynamic view of brain pathophysiology.

Authors:  Tony W Wilson; Elizabeth Heinrichs-Graham; Amy L Proskovec; Timothy J McDermott
Journal:  Transl Res       Date:  2016-01-25       Impact factor: 7.012

2.  HIV infection is associated with attenuated frontostriatal intrinsic connectivity: a preliminary study.

Authors:  Jonathan C Ipser; Gregory G Brown; Amanda Bischoff-Grethe; Colm G Connolly; Ronald J Ellis; Robert K Heaton; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2015-03-31       Impact factor: 2.892

Review 3.  Aberrant brain dynamics in neuroHIV: Evidence from magnetoencephalographic (MEG) imaging.

Authors:  Tony W Wilson; Brandon J Lew; Rachel K Spooner; Michael T Rezich; Alex I Wiesman
Journal:  Prog Mol Biol Transl Sci       Date:  2019-05-23       Impact factor: 3.622

4.  Frequency and Correlates of Subjective Cognitive Impairment in HIV Disease.

Authors:  David P Sheppard; Steven Paul Woods; Paul J Massman; Paul E Gilbert
Journal:  AIDS Behav       Date:  2019-03

5.  Functional brain abnormalities during finger-tapping in HIV-infected older adults: a magnetoencephalography study.

Authors:  Tony W Wilson; Elizabeth Heinrichs-Graham; Kevin R Robertson; Uriel Sandkovsky; Jennifer O'Neill; Nichole L Knott; Howard S Fox; Susan Swindells
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-09       Impact factor: 4.147

6.  Multimodal neuroimaging evidence of alterations in cortical structure and function in HIV-infected older adults.

Authors:  Tony W Wilson; Elizabeth Heinrichs-Graham; Katherine M Becker; Joseph Aloi; Kevin R Robertson; Uriel Sandkovsky; Matthew L White; Jennifer O'Neill; Nichole L Knott; Howard S Fox; Susan Swindells
Journal:  Hum Brain Mapp       Date:  2014-11-06       Impact factor: 5.038

7.  Brain structural and functional recovery following initiation of combination antiretroviral therapy.

Authors:  James T Becker; Pablo Cuesta; Melissa Fabrizio; Gustavo Sudre; Emanuel N Vergis; Antoine Douaihy; Ricardo Bajo; Allie Schubert; Oscar L Lopez; Lauri Parkkonen; Fernando Maestu; Anto Bagic
Journal:  J Neurovirol       Date:  2012-06-13       Impact factor: 2.643

8.  Decreased MEG beta oscillations in HIV-infected older adults during the resting state.

Authors:  Katherine M Becker; Elizabeth Heinrichs-Graham; Howard S Fox; Kevin R Robertson; Uriel Sandkovsky; Jennifer O'Neill; Susan Swindells; Tony W Wilson
Journal:  J Neurovirol       Date:  2013-12-03       Impact factor: 2.643

9.  Cortical brain atrophy and intra-individual variability in neuropsychological test performance in HIV disease.

Authors:  Lindsay J Hines; Eric N Miller; Charles H Hinkin; Jeffery R Alger; Peter Barker; Karl Goodkin; Eileen M Martin; Victoria Maruca; Ann Ragin; Ned Sacktor; Joanne Sanders; Ola Selnes; James T Becker
Journal:  Brain Imaging Behav       Date:  2016-09       Impact factor: 3.978

10.  Brain structural correlates of trajectories to cognitive impairment in men with and without HIV disease.

Authors:  Mikhail Popov; Samantha A Molsberry; Fabrizio Lecci; Brian Junker; Lawrence A Kingsley; Andrew Levine; Eileen Martin; Eric Miller; Cynthia A Munro; Ann Ragin; Eric Seaberg; Ned Sacktor; James T Becker
Journal:  Brain Imaging Behav       Date:  2020-06       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.